BioSig Technologies, Inc. (BSGM)
USD 0.49
(-2.65%)
USD 0.49
(-2.65%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 262 Thousand USD | -35.78% |
| 2022 | 408 Thousand USD | 103.71% |
| 2021 | -11 Million USD | 60.64% |
| 2020 | -27.95 Million USD | -145.53% |
| 2019 | -11.38 Million USD | -155.84% |
| 2018 | -4.45 Million USD | -187.56% |
| 2017 | -1.54 Million USD | -46.57% |
| 2016 | -1.05 Million USD | -10.77% |
| 2015 | -953.23 Thousand USD | -138.57% |
| 2014 | 2.47 Million USD | 1010.52% |
| 2013 | -271.4 Thousand USD | -1019.8% |
| 2012 | -24.23 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 452 Thousand USD | 72.52% |
| 2024 Q2 | -1.82 Million USD | -503.1% |
| 2023 Q3 | 143 Thousand USD | 122.34% |
| 2023 Q4 | 262 Thousand USD | 83.22% |
| 2023 FY | 262 Thousand USD | -35.78% |
| 2023 Q1 | -723 Thousand USD | -277.21% |
| 2023 Q2 | -640 Thousand USD | 11.48% |
| 2022 Q3 | -5000.00 USD | 99.88% |
| 2022 Q4 | 408 Thousand USD | 8260.0% |
| 2022 Q1 | -8.09 Million USD | 26.43% |
| 2022 FY | 408 Thousand USD | 103.71% |
| 2022 Q2 | -4.12 Million USD | 49.02% |
| 2021 FY | -11 Million USD | 60.64% |
| 2021 Q3 | -16.83 Million USD | -10.35% |
| 2021 Q4 | -11 Million USD | 34.64% |
| 2021 Q1 | -22.11 Million USD | 20.88% |
| 2021 Q2 | -15.25 Million USD | 31.02% |
| 2020 FY | -27.95 Million USD | -145.53% |
| 2020 Q1 | -14.87 Million USD | -30.65% |
| 2020 Q2 | -36.4 Million USD | -144.73% |
| 2020 Q3 | -32.32 Million USD | 11.19% |
| 2020 Q4 | -27.95 Million USD | 13.53% |
| 2019 Q2 | -9.51 Million USD | 9.81% |
| 2019 FY | -11.38 Million USD | -155.84% |
| 2019 Q1 | -10.54 Million USD | -137.03% |
| 2019 Q3 | -11.56 Million USD | -21.6% |
| 2019 Q4 | -11.38 Million USD | 1.58% |
| 2018 Q3 | -7.27 Million USD | -98.18% |
| 2018 FY | -4.45 Million USD | -187.56% |
| 2018 Q4 | -4.45 Million USD | 38.87% |
| 2018 Q2 | -3.67 Million USD | -254.86% |
| 2018 Q1 | -1.03 Million USD | 33.11% |
| 2017 Q1 | -1.24 Million USD | -17.83% |
| 2017 Q2 | -880.65 Thousand USD | 29.21% |
| 2017 Q3 | -234.28 Thousand USD | 73.4% |
| 2017 Q4 | -1.54 Million USD | -560.55% |
| 2017 FY | -1.54 Million USD | -46.57% |
| 2016 Q1 | -137.61 Thousand USD | 85.56% |
| 2016 FY | -1.05 Million USD | -10.77% |
| 2016 Q3 | -150.45 Thousand USD | 78.67% |
| 2016 Q4 | -1.05 Million USD | -601.81% |
| 2016 Q2 | -705.34 Thousand USD | -412.55% |
| 2015 Q1 | -2.05 Million USD | -183.33% |
| 2015 Q4 | -953.23 Thousand USD | -184.92% |
| 2015 Q3 | -334.55 Thousand USD | 72.06% |
| 2015 Q2 | -1.19 Million USD | 41.86% |
| 2015 FY | -953.23 Thousand USD | -138.57% |
| 2014 Q2 | -41.68 Thousand USD | -911.84% |
| 2014 Q3 | 2.51 Million USD | 6126.01% |
| 2014 Q4 | 2.47 Million USD | -1.63% |
| 2014 Q1 | 5135.00 USD | 101.89% |
| 2014 FY | 2.47 Million USD | 1010.52% |
| 2013 Q3 | 163.01 Thousand USD | -89.58% |
| 2013 Q1 | -428.38 Thousand USD | -1667.49% |
| 2013 Q2 | 1.56 Million USD | 465.14% |
| 2013 FY | -271.4 Thousand USD | -1019.8% |
| 2013 Q4 | -271.4 Thousand USD | -266.49% |
| 2012 Q4 | -24.23 Thousand USD | 0.0% |
| 2012 FY | -24.23 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 27.08 Million USD | 99.033% |
| BrainsWay Ltd. | -10.32 Million USD | 102.539% |
| Cerus Corporation | 84.35 Million USD | 99.689% |
| Envoy Medical, Inc. | -3.81 Million USD | 106.869% |
| electroCore, Inc. | -9.95 Million USD | 102.632% |
| Helius Medical Technologies, Inc. | -5.12 Million USD | 105.112% |
| IceCure Medical Ltd | -9.93 Million USD | 102.637% |
| Inogen, Inc. | -103.56 Million USD | 100.253% |
| OrthoPediatrics Corp. | -9.26 Million USD | 102.827% |
| Lucid Diagnostics Inc. | -3.64 Million USD | 107.196% |
| Monogram Orthopaedics, Inc. | -13.09 Million USD | 102.0% |
| MaxCyte, Inc. | -27.76 Million USD | 100.944% |
| NeuroOne Medical Technologies Corporation | -5.13 Million USD | 105.099% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 145.505% |
| Orthofix Medical Inc. | 96.44 Million USD | 99.728% |
| PAVmed Inc | 29.08 Million USD | 99.099% |
| Rapid Micro Biosystems, Inc. | -16.93 Million USD | 101.547% |
| RxSight, Inc. | -6.68 Million USD | 103.922% |
| Sight Sciences, Inc. | -102.71 Million USD | 100.255% |
| SI-BONE, Inc. | 5.72 Million USD | 95.42% |
| TELA Bio, Inc. | -3.94 Million USD | 106.635% |
| Treace Medical Concepts, Inc. | 57.32 Million USD | 99.543% |
| Vivos Therapeutics, Inc. | 352 Thousand USD | 25.568% |
| Acutus Medical, Inc. | 12.27 Million USD | 97.866% |
| Talis Biomedical Corporation | -57.06 Million USD | 100.459% |
| Spectral AI, Inc. | -3.5 Million USD | 107.484% |
| Nano-X Imaging Ltd. | -48.02 Million USD | 100.546% |
| CVRx, Inc. | -59.95 Million USD | 100.437% |
| DIH Holding US, Inc. Warrants | 1.98 Million USD | 86.795% |
| PetVivo Holdings, Inc. | 1.27 Million USD | 79.493% |
| Bioventus Inc. | 372.51 Million USD | 99.93% |
| Venus Concept Inc. | 74.3 Million USD | 99.647% |
| TriSalus Life Sciences, Inc. | -10.18 Million USD | 102.573% |
| LivaNova PLC | 62.53 Million USD | 99.581% |
| 908 Devices Inc. | -115.09 Million USD | 100.228% |
| Alphatec Holdings, Inc. | 320.7 Million USD | 99.918% |
| Nemaura Medical Inc. | 9.92 Million USD | 97.36% |
| NeuroPace, Inc. | 54.33 Million USD | 99.518% |
| LENSAR, Inc. | -18.31 Million USD | 101.431% |
| Apyx Medical Corporation | -5.15 Million USD | 105.086% |
| Cutera, Inc. | 288.3 Million USD | 99.909% |
| STRATA Skin Sciences, Inc. | 7.51 Million USD | 96.514% |
| Anika Therapeutics, Inc. | -43.83 Million USD | 100.598% |
| ClearPoint Neuro, Inc. | -9.19 Million USD | 102.848% |
| Integra LifeSciences Holdings Corporation | 1.4 Billion USD | 99.981% |
| Axonics, Inc. | -77.19 Million USD | 100.339% |
| Outset Medical, Inc. | 67.67 Million USD | 99.613% |
| IRIDEX Corporation | -4.28 Million USD | 106.11% |
| PROCEPT BioRobotics Corporation | -178.01 Million USD | 100.147% |
| IRadimed Corporation | -47.71 Million USD | 100.549% |
| Tivic Health Systems, Inc. | -3.02 Million USD | 108.658% |
| INVO Bioscience, Inc. | 8.45 Million USD | 96.9% |
| Telesis Bio, Inc. | 32.63 Million USD | 99.197% |
| Viemed Healthcare, Inc. | -2.5 Million USD | 110.471% |
| Varex Imaging Corporation | 316.9 Million USD | 99.917% |
| Quipt Home Medical Corp. | 81.73 Million USD | 99.679% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 109.418% |
| Pulmonx Corporation | -42.36 Million USD | 100.619% |
| Dynatronics Corporation | 6.2 Million USD | 95.777% |
| Modular Medical, Inc. | -8.04 Million USD | 103.258% |
| ReShape Lifesciences Inc. | -4.29 Million USD | 106.097% |
| Semler Scientific, Inc. | -57.13 Million USD | 100.459% |
| InMode Ltd. | -135.39 Million USD | 100.194% |
| Bruker Corporation | 891.3 Million USD | 99.971% |
| Cytosorbents Corporation | 4.18 Million USD | 93.735% |
| DexCom, Inc. | 2.02 Billion USD | 99.987% |
| Align Technology, Inc. | -840.47 Million USD | 100.031% |
| Viveve Medical, Inc. | -13.81 Million USD | 101.897% |
| ZimVie Inc. | 450.41 Million USD | 99.942% |
| Movano Inc. | -5.86 Million USD | 104.466% |
| Cytek Biosciences, Inc. | -134.45 Million USD | 100.195% |
| Nexalin Technology, Inc. | -575.76 Thousand USD | 145.505% |
| DIH Holdings US, Inc. Class A Common Stock | 1.98 Million USD | 86.795% |
| Tandem Diabetes Care, Inc. | 356.79 Million USD | 99.927% |
| Profound Medical Corp. | -18.17 Million USD | 101.441% |
| Insulet Corporation | 798.1 Million USD | 99.967% |
| enVVeno Medical Corporation | -2.21 Million USD | 111.812% |
| Surmodics, Inc. | -12.01 Million USD | 102.181% |
| iCAD, Inc. | -21.2 Million USD | 101.235% |
| Nuwellis, Inc. | -2.81 Million USD | 109.294% |
| Biotricity, Inc. | 23.09 Million USD | 98.865% |
| iRhythm Technologies, Inc. | 93.65 Million USD | 99.72% |
| Aethlon Medical, Inc. | -4.5 Million USD | 105.82% |
| InspireMD, Inc. | -8.04 Million USD | 103.257% |
| PAVmed Inc. | 29.08 Million USD | 99.099% |
| BIOLASE, Inc. | 11.34 Million USD | 97.69% |
| Beyond Air, Inc. | 6.22 Million USD | 95.794% |
| FONAR Corporation | -14.66 Million USD | 101.787% |
| AxoGen, Inc. | 32.26 Million USD | 99.188% |
| Vivani Medical, Inc. | 42 Thousand USD | -523.81% |
| Tactile Systems Technology, Inc. | -10.65 Million USD | 102.458% |
| Inari Medical, Inc. | -7.16 Million USD | 103.659% |
| UFP Technologies, Inc. | 40.77 Million USD | 99.357% |
| QT Imaging Holdings, Inc. | 3.06 Million USD | 91.462% |
| Heart Test Laboratories, Inc. | -4.77 Million USD | 105.491% |
| Tenon Medical, Inc. | -1.25 Million USD | 120.876% |
| Autonomix Medical, Inc. Common Stock | -7.6 Million USD | 103.445% |
| Co-Diagnostics, Inc. | -11.92 Million USD | 102.197% |
| AdaptHealth Corp. | 2.21 Billion USD | 99.988% |
| Sintx Technologies, Inc. | 905 Thousand USD | 71.05% |
| NanoVibronix, Inc. | -3.27 Million USD | 107.993% |
| Quanterix Corporation | -132.95 Million USD | 100.197% |
| Inspira Technologies Oxy B.H.N. Ltd. | -2.78 Million USD | 109.418% |
| Sensus Healthcare, Inc. | -22.36 Million USD | 101.171% |
| Pacific Biosciences of California, Inc. | 753.71 Million USD | 99.965% |
| TransMedics Group, Inc. | 121.13 Million USD | 99.784% |
| ReWalk Robotics Ltd. | -26.18 Million USD | 101.001% |
| NeuroMetrix, Inc. | -1.49 Million USD | 117.571% |
| Hyperfine, Inc. | -75.61 Million USD | 100.346% |
| Establishment Labs Holdings Inc. | 152.18 Million USD | 99.828% |
| Biomerica, Inc. | -3.38 Million USD | 107.74% |
| Bone Biologics Corporation | -3.02 Million USD | 108.657% |
| AVITA Medical, Inc. | -26.23 Million USD | 100.999% |
| Bluejay Diagnostics, Inc. | -1.83 Million USD | 114.251% |
| Silk Road Medical, Inc | 64.42 Million USD | 99.593% |